[Federal Register Volume 87, Number 13 (Thursday, January 20, 2022)]
[Notices]
[Pages 3110-3111]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-01084]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; PDAC Stromal Reprogramming Consortium (PSRC).
    Date: March 3, 2022.
    Time: 11:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W240, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Hasan Siddiqui, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W240, Rockville, Maryland 20850, 240-276-5122, 
<a href="/cdn-cgi/l/email-protection#e48c8597858aca978d80808d95918da48a8d8cca838b92"><span class="__cf_email__" data-cfemail="3d555c4e5c53134e545959544c48547d535455135a524b">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Research Centers for Cancer Systems Biology and DCB Multi-
Consortia Coordinating Center Review.
    Date: March 7-8, 2022.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W104, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Eun Ah Cho, Ph.D., Scientific Review Officer, 
Resources and Training Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W104, Rockville, Maryland 20850, 240-276-6342, 
<a href="/cdn-cgi/l/email-protection#3053585f55705d51595c1e5e59581e575f46"><span class="__cf_email__" data-cfemail="6e0d06010b2e030f07024000070640090118">[email protected]</span></a>.


[[Page 3111]]


    Name of Committee: National Cancer Institute Special Emphasis 
Panel; HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials 
Network.
    Date: March 8, 2022.
    Time: 12:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W248, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Shree Ram Singh, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W248, Rockville, Maryland 20850, 240-672-6175, 
<a href="/cdn-cgi/l/email-protection#fd8e94939a958e958fbd909c9491d3939495d39a928b"><span class="__cf_email__" data-cfemail="e4978d8a838c978c96a489858d88ca8a8d8cca838b92">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Cancer Control in People Living with HIV in LMIC (U01).
    Date: March 10, 2022.
    Time: 10:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W240, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Hasan Siddiqui, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W240, Rockville, Maryland 20850, 240-276-5122, 
<a href="/cdn-cgi/l/email-protection#5931382a3837772a303d3d30282c3019373031773e362f"><span class="__cf_email__" data-cfemail="432b2230222d6d302a27272a32362a032d2a2b6d242c35">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Investigation of the Transmission of Kaposi Sarcoma-
Associated Herpesvirus.
    Date: March 23, 2022.
    Time: 10:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W618, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Mukesh Kumar, Ph.D., Scientific Review Officer, 
Research Programs Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W618, Rockville, Maryland 20850, 240-276-6611, 
<a href="/cdn-cgi/l/email-protection#6e031b050b1d0640051b030f1c5d2e00070640090118"><span class="__cf_email__" data-cfemail="98f5edf3fdebf0b6f3edf5f9eaabd8f6f1f0b6fff7ee">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; TEP-10: SBIR Contract Review Meeting.
    Date: March 24, 2022.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W126, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Susan Lynn Spence, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W126, Rockville, Maryland 20850, 240-620-0819, 
<a href="/cdn-cgi/l/email-protection#e4979197858aca9794818a8781a48a8d8cca838b92"><span class="__cf_email__" data-cfemail="1d6e686e7c73336e6d78737e785d737475337a726b">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Cancer Target Discovery and Development (CTD2) Review 
Meeting.
    Date: March 24, 2022.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W116, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Klaus B. Piontek, Ph.D., Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7116, Rockville, Maryland 20850, 240-276-5413, 
<a href="/cdn-cgi/l/email-protection#94fff8f5e1e7bae4fdfbfae0f1ffd4fafdfcbaf3fbe2"><span class="__cf_email__" data-cfemail="bed5d2dfcbcd90ced7d1d0cadbd5fed0d7d690d9d1c8">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Initial Review 
Group; Cancer Centers Study Section (A).
    Date: May 12, 2022.
    Time: 10:30 a.m. to 1:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W530, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Shamala K. Srinivas, Ph.D., Associate Director, 
Office of Referral, Review, and Program Coordination, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W530, Rockville, Maryland 20850, 240-276-6442, 
<a href="/cdn-cgi/l/email-protection#a4d7d7919793d0e4cacdcc8ac3cbd2"><span class="__cf_email__" data-cfemail="4b38387e787c3f0b252223652c243d">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: January 14, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-01084 Filed 1-19-22; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>